EUVIMEDEUVIMED entdecken
Crossref

Endoscopic retrograde appendicitis therapy (ERAT) for treating periappendiceal abscess: A multicentral experience from China

S. Ullah, J. Zhang, L. Dan, L. Jianyi, F. Jianping, B. Liu

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S366

DOI: 10.1055/s-0044-1783601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von S. Ullah und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The aim of this study was to evaluate the safety and efficacy of endoscopic retrograde appendicitis therapy (ERAT) for treating periappendiceal abscess.

Methods

Twenty-four consecutive periappendiceal abscess patients who underwent ERAT between May 2017 and May 2022 at three tertiary care Hospitals in China were included in this study. The diagnosis of periappendiceal abscess was confirmed by direct colonoscopy imaging and computed tomography (CT) and/or ultrasonography (US). The baseline characteristics of all the patients, procedure success rate, procedure time, postoperative length of hospital stay, complications, and recurrence rate were recorded.

Results

The success rate of ERAT was 95.8% (intubation failed in one patient due to the closure/blockage of the appendiceal opening). The mean procedure time was 33.79 minutes with standard deviation (SD) of 17.1 min. The mean length of postoperative hospital stay was 5.4 (SD 2.6) days. Time to relief of abdominal pain after the ERAT was 28.2±19.4 hours. No complication observed in any of the patient. Antibiotics were routinely administered for 3 days after the ERAT. Recurrence occurred in 8.7% of the patents at mean 26.9 (SD 10) months of follow-up.

Conclusions

Preliminary evidence suggests that ERAT could be a safe and effective alternative option for treating periappendiceal abscess, making it a valuable addition to the armamentarium of interventional endoscopy. The practice of ERAT currently remains predominantly limited to the Eastern world. As the treatment paradigm of appendicitis evolves, it is crucial that novel techniques such as ERAT be evaluated at a global scale alongside the evolving standard of care therapies. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Ullah, S., Zhang, J., Dan, L., Jianyi, L., Jianping, F., & Liu, B. (2024). Endoscopic retrograde appendicitis therapy (ERAT) for treating periappendiceal abscess: A multicentral experience from China. Endoscopy, 56(S 02 S 02), S366. https://doi.org/10.1055/s-0044-1783601

Vancouver

Ullah S, Zhang J, Dan L, Jianyi L, Jianping F, Liu B. Endoscopic retrograde appendicitis therapy (ERAT) for treating periappendiceal abscess: A multicentral experience from China. Endoscopy. 2024;56(S 02 S 02):S366. doi:10.1055/s-0044-1783601

BibTeX
@article{Ullah2024,
  author = {Ullah, S. and Zhang, J. and Dan, L. and Jianyi, L. and Jianping, F. and Liu, B.},
  title = {Endoscopic retrograde appendicitis therapy (ERAT) for treating periappendiceal abscess: A multicentral experience from China},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S366},
  doi = {10.1055/s-0044-1783601}
}
Kostenlos starten →